Cargando…

The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)

BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent co...

Descripción completa

Detalles Bibliográficos
Autores principales: Stedman, Mike, Rea, Rustam, Duff, Christopher J., Livingston, Mark, McLoughlin, Katie, Wong, Louise, Brown, Stephen, Grady, Katherine, Gadsby, Roger, Gibson, John M., Paisley, Angela, Fryer, Anthony A., Heald, Adrian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917860/
https://www.ncbi.nlm.nih.gov/pubmed/34921531
http://dx.doi.org/10.1002/edm2.302
_version_ 1784668637403021312
author Stedman, Mike
Rea, Rustam
Duff, Christopher J.
Livingston, Mark
McLoughlin, Katie
Wong, Louise
Brown, Stephen
Grady, Katherine
Gadsby, Roger
Gibson, John M.
Paisley, Angela
Fryer, Anthony A.
Heald, Adrian H.
author_facet Stedman, Mike
Rea, Rustam
Duff, Christopher J.
Livingston, Mark
McLoughlin, Katie
Wong, Louise
Brown, Stephen
Grady, Katherine
Gadsby, Roger
Gibson, John M.
Paisley, Angela
Fryer, Anthony A.
Heald, Adrian H.
author_sort Stedman, Mike
collection PubMed
description BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent comprehensive assessment of the performance of BG monitoring strips or the patient experience of BG strips in people with T2DM in the UK. METHODS: An online self‐reported questionnaire containing 44 questions, prepared following consultation with clinicians and patients, was circulated to people with T2DM. 186 responders provided completed responses (25.5% return rate). Fixed responses were coded numerically (eg not confident = 0 fairly confident = 1). RESULTS: Of responders, 84% were treated with insulin in addition to other agents. 75% reported having had an HbA1c check in the previous 6 months. For those with reported HbA1c ≥ 65 mmol/mol, a majority of people (70%) were concerned or really concerned about the shorter term consequences of running a high HbA1c This contrasted with those who did not know their recent HbA1c, of whom only 33% were concerned/really concerned and those with HbA1c <65 mmol/mol of whom 35% were concerned. Regarding BG monitoring/insulin adjustment, only 25% of responders reported having sufficient information with 13% believing that the accuracy and precision of their BG metre was being independently checked. Only 9% recalled discussing BG metre accuracy when their latest metre was provided and only 7% were aware of the International Standardisation Organisation (ISO) standards for BG metres. 77% did not recall discussing BG metre performance with a healthcare professional. CONCLUSION: The group surveyed comprised engaged people with T2DM but even within this group there was significant variation in (a) awareness of shorter term risks, (b) confidence in their ability to implement appropriate insulin dosage (c) awareness of the limitations of BG monitoring technology. There is clearly an area where changes in education/support would benefit many.
format Online
Article
Text
id pubmed-8917860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89178602022-03-18 The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) Stedman, Mike Rea, Rustam Duff, Christopher J. Livingston, Mark McLoughlin, Katie Wong, Louise Brown, Stephen Grady, Katherine Gadsby, Roger Gibson, John M. Paisley, Angela Fryer, Anthony A. Heald, Adrian H. Endocrinol Diabetes Metab Original Research Article BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent comprehensive assessment of the performance of BG monitoring strips or the patient experience of BG strips in people with T2DM in the UK. METHODS: An online self‐reported questionnaire containing 44 questions, prepared following consultation with clinicians and patients, was circulated to people with T2DM. 186 responders provided completed responses (25.5% return rate). Fixed responses were coded numerically (eg not confident = 0 fairly confident = 1). RESULTS: Of responders, 84% were treated with insulin in addition to other agents. 75% reported having had an HbA1c check in the previous 6 months. For those with reported HbA1c ≥ 65 mmol/mol, a majority of people (70%) were concerned or really concerned about the shorter term consequences of running a high HbA1c This contrasted with those who did not know their recent HbA1c, of whom only 33% were concerned/really concerned and those with HbA1c <65 mmol/mol of whom 35% were concerned. Regarding BG monitoring/insulin adjustment, only 25% of responders reported having sufficient information with 13% believing that the accuracy and precision of their BG metre was being independently checked. Only 9% recalled discussing BG metre accuracy when their latest metre was provided and only 7% were aware of the International Standardisation Organisation (ISO) standards for BG metres. 77% did not recall discussing BG metre performance with a healthcare professional. CONCLUSION: The group surveyed comprised engaged people with T2DM but even within this group there was significant variation in (a) awareness of shorter term risks, (b) confidence in their ability to implement appropriate insulin dosage (c) awareness of the limitations of BG monitoring technology. There is clearly an area where changes in education/support would benefit many. John Wiley and Sons Inc. 2021-12-17 /pmc/articles/PMC8917860/ /pubmed/34921531 http://dx.doi.org/10.1002/edm2.302 Text en © 2021 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Stedman, Mike
Rea, Rustam
Duff, Christopher J.
Livingston, Mark
McLoughlin, Katie
Wong, Louise
Brown, Stephen
Grady, Katherine
Gadsby, Roger
Gibson, John M.
Paisley, Angela
Fryer, Anthony A.
Heald, Adrian H.
The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
title The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
title_full The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
title_fullStr The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
title_full_unstemmed The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
title_short The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
title_sort experience of blood glucose monitoring in people with type 2 diabetes mellitus (t2dm)
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917860/
https://www.ncbi.nlm.nih.gov/pubmed/34921531
http://dx.doi.org/10.1002/edm2.302
work_keys_str_mv AT stedmanmike theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT rearustam theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT duffchristopherj theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT livingstonmark theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT mcloughlinkatie theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT wonglouise theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT brownstephen theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT gradykatherine theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT gadsbyroger theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT gibsonjohnm theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT paisleyangela theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT fryeranthonya theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT healdadrianh theexperienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT stedmanmike experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT rearustam experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT duffchristopherj experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT livingstonmark experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT mcloughlinkatie experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT wonglouise experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT brownstephen experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT gradykatherine experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT gadsbyroger experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT gibsonjohnm experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT paisleyangela experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT fryeranthonya experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm
AT healdadrianh experienceofbloodglucosemonitoringinpeoplewithtype2diabetesmellitust2dm